Cargando…
Metabolomic Profiling Revealed Potential Biomarkers in Patients With Moyamoya Disease
Metabolomics is increasingly used to observe metabolic patterns and disease-specific metabolic biomarkers. However, serum metabolite analysis of moyamoya disease (MMD) is rarely reported. We investigated serum metabolites in MMD and compared them with those of healthy controls (HCs) using a non-targ...
Autores principales: | Geng, Chunmei, Cui, Changmeng, Guo, Yujin, Wang, Changshui, Zhang, Jun, Han, Wenxiu, Jin, Feng, Chen, Dan, Jiang, Pei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186471/ https://www.ncbi.nlm.nih.gov/pubmed/32372905 http://dx.doi.org/10.3389/fnins.2020.00308 |
Ejemplares similares
-
Comprehensive Evaluation of Lipopolysaccharide-Induced Changes in Rats Based on Metabolomics
por: Geng, Chunmei, et al.
Publicado: (2020) -
Association of Brain-Gut Peptides with Inflammatory Cytokines in Moyamoya Disease
por: Han, Wenxiu, et al.
Publicado: (2020) -
Systematic Evaluations of Doxorubicin-Induced Toxicity
in Rats Based on Metabolomics
por: Geng, Chunmei, et al.
Publicado: (2020) -
Systematic impacts of chronic unpredictable mild stress on metabolomics in rats
por: Geng, Chunmei, et al.
Publicado: (2020) -
A GC–MS-based untargeted metabolomics approach for comprehensive metabolic profiling of vancomycin-induced toxicity in mice
por: Cui, Changmeng, et al.
Publicado: (2022)